Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Disease area: Airway diseases

Abstract

Background: Patients with aspirin induced asthma (AIA) experience varying degrees of adverse respiratory reactions after use of nonsteroidal anti-inflammatory drugs (NSAIDs). The effect of oral challenges with different NSAIDs on fractional exhaled nitric oxide(FeNO) as a marker of airway inflammation has notbeen thoroughly investigated.Objectives: To investigate the effect of oral challenges with 3 different NSAIDs, namely Aspirin (ASA), nimesulide (NIM) and celecoxib(CEL) on FeNO values in patients with AIA.Methods: Oral challenge with all 3 drugs was performed in 30 patients with AIA and 15 patients with Aspirin Tolerant Asthma (ATA), compared with 15 normal subjects.Results: Patients with AIA and ATA had baseline FeNO significantly higher than controls (26.06 ± 7.74 and 23.74 ± 3.27 vs. 9.55 ± 2.00 p.p.b. respectively, p<0.001). During Oral Challenge with Aspirin (OAC) FeNO levels increased significantly only in patients with AIA, starting to rise 45 minutes after the administration of the first dose (27 mg) of aspirin and reaching a peak value about 6 hours after the beginning of OAC ( 53.14 ± 15.07 p.p.b., vs26.06 ± 7.74 p<0.001). Statistically significant, although lower, increase in FeNO peak values was also observed only in patients with AIA during oral challenges with NIM and CEL (34.03 ± 11.3 p.p.b. vs 25,84 ±8,26 and 27.85 ± 8.98 p.p.b. vs 25,49 ± 8,23 respectively).Conclusion: FeNO seems to be a sensitive and early marker of inflammation in patients with AIA receiving NSAIDs. The safety of COX-2 inhibitors seems to be further supported by the minimal increase in FeNO.


Rating:

Share or cite this content

Citations should be made in the following way:
Konstantinos Porpodis (Thessaloniki, Greece), Lambros Ganavias, Konstantinos Porpodis, Konstantinos Katsoulis, Dimitrios Gioulekas, Lazaros Sichletidis, Konstantinos Zarogoulidis, Despoina Papakosta. Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma. Eur Respir J 2016; 48: Suppl. 60, 577

Member's Comments

No comment yet.

Related content which might interest you: The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis Source: International Congress 2016 – Airway biomarkers Year: 2016 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 The effect of bronchodilation and spirometry on exhaled nitric oxide Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study Source: Eur Respir J 2011; 37: 523-531 Year: 2011 Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007 Exhaled nitric oxide and the therapeutic regimens in childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Alveolar nitric oxide and its role in asthma control assessment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide in children with severe asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Exhaled nitric oxide and clinical phenotype of childhood asthma Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 Exhaled nitric oxide is related to asthma control but not severity Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 Exhaled nitric oxide in childhood asthma Source: Annual Congress 2006 - Paediatric Respiratory Research Award Year: 2006